Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    7755231 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: switch to Myfortic;   Drug: continuation of azathioprine

Indicates status has not been verified in more than two years